All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Viral Infections and New Approaches to Their Treatment

DOI: 10.4236/oalib.1106384, PP. 1-8

Subject Areas: Infectious Diseases

Keywords: Viruses, Conditionally Pathogenic Bacteria, Staphylococci, Deoxyribonuclease, Bacterial Restrictase

Full-Text   Cite this paper   Add to My Lib

Abstract

The article discusses a new version of the fight against viral infections. The use of certain bacterial enzymes that can possibly be used to destroy viral RNA and DNA is discussed. The proposed hypothesis is based on the available data regarding the struggle of bacteria with their viruses that infect themselves. Since opportunistic bacteria are capable of producing certain enzymes, in particular staphylococcal DNase and other bacterial restriction enzymes, they can cope with their own viruses, and may also be used to fight viruses that infect the human body.

Cite this paper

Gevorkyan, L. and Jashi, I. (2020). Viral Infections and New Approaches to Their Treatment. Open Access Library Journal, 7, e6384. doi: http://dx.doi.org/10.4236/oalib.1106384.

References

[1]  Kloos, W.E. (1980) Natural Populations of the Genus Staphylococcus. Annual Review of Microbiology, 34, 559-592. https://doi.org/10.1146/annurev.mi.34.100180.003015
[2]  Kluytmans, J., van Belkum, A. and Verbrugh, H. (1997) Nasal Carriage of Staphylococcus aureus: Epidemiology, Underlying Mechanisms, and Associated Risks. Clinical Microbiology Reviews, 10, 505-520. https://doi.org/10.1128/CMR.10.3.505-520.1997
[3]  Tong, S.Y., Davis, J.S., Eichenberger, E., Holland, T.L. and Fowler, V.G. (2015) Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clinical Microbiology Reviews, 28, 603-661. https://doi.org/10.1128/CMR.00134-14
[4]  Ryan, K.J. and Ray, C.G., Eds. (2004) Sherris Medical Microbiology. 4th Edition, McGraw-Hill, New York.
[5]  Kazantsev, A.P. and Matkovsky, V.S. (1986) Infectious Disease Handbook. 3rd Edition, Medicine, Moscow.
[6]  Dinges, M.M., Orwin, P.M. and Schlievert, P.M. (2000) Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews, 13, 16-34. https://doi.org/10.1128/CMR.13.1.16
[7]  Jarraud, S., Peyrat, M.A., Lim, A., Tristan, A., Bes, M., Mougel, C., Etienne, J., Vandenesch, F., Bonneville, M. and Lina, G. (2001) egc, a Highly Prevalent Operon of Enterotoxin Gene, Forms a Putative Nursery of Superantigens in Staphylococcus aureus. Journal of Immunology, 166, 669-677. https://doi.org/10.4049/jimmunol.166.1.669
[8]  Becker, K., Friedrich, A.W., Lubritz, G., Weilert, M., Peters, G. and Von Eiff, C. (2003) Prevalence of Genes Encoding Pyrogenic Toxin Superantigens and Exfoliative Toxins among Strains of Staphylococcus aureus Isolated from Blood and Nasal Specimens. Journal of Clinical Microbiology, 41, 1434-1439. https://doi.org/10.1128/JCM.41.4.1434-1439.2003
[9]  Rybicki, E.P. (2015) A Top Ten List for Economically Important Plant Viruses. Archives of Virology, 160, 17-20. https://doi.org/10.1007/s00705-014-2295-9
[10]  Dinesh-Kumar, S.P., Tham, W.-H. and Baker, B.J. (2000) Structure-Function Analysis of the Tobacco Mosaic Virus Resistance Gene N. Proceedings of the National Academy of Sciences of the United States of America, 97, 14789-14794. https://doi.org/10.1073/pnas.97.26.14789
[11]  Bickle, T.A. and Kruger, D.H. (1993) Biology of DNA Restriction. Microbiology and Molecular Biology Reviews, 57, 434-450. https://doi.org/10.1128/MMBR.57.2.434-450.1993
[12]  Barrangou, R., Fremaux, C., Deveau, H., et al. (2007) CRISPR Provides Acquired Resistance against Viruses in Prokaryotes. Science, 315, 1709-1712. https://doi.org/10.1126/science.1138140
[13]  Brouns, S.J., Jore, M.M., Lundgren, M., et al. (2008) Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes. Science, 321, 960-964. https://doi.org/10.1126/science.1159689
[14]  Roberts, R.J., Vincze, T., Posfai, J. and Macelis, D (2007) REBASE—Enzymes and Genes for DNA Restriction and Modification. Nucleic Acids Research, 35, D269-D270. https://doi.org/10.1093/nar/gkl891
[15]  Roberts, R.J. (1976) Restriction Endonucleases. CRC Critical Reviews in Biochemistry, 4, 123-164. https://doi.org/10.3109/10409237609105456
[16]  Kessler, C. and Manta, V. (1990) Specificity of Restriction Endonucleases and DNA Modification Methyltransferases: A Review (Edition 3). Gene, 92, 1-240. https://doi.org/10.1016/0378-1119(90)90486-B
[17]  Pingoud, A., Alves, J. and Geiger, R. (1993) Chapter 8: Restriction Enzymes. In: Burrell, M., Ed., Enzymes of Molecular Biology, Humana Press, Totowa, NJ, 107-200.
[18]  Kobayashi, I. (2001) Behavior of Restriction-Modification Systems as Selfish Mobile Elements and Their Impact on Genome Evolution. Nucleic Acids Research, 29, 3742-3756. https://doi.org/10.1093/nar/29.18.3742
[19]  Bowen, R.A., Austgen, L. and Rouge, M. (2004) Restriction Endonucleases and DNA Modifying Enzymes (2017) Nucleases: DNase and RNase, Biotechnology and Genetic Engineering. http://arbl.cvmbs.colostate.edu/hbooks/genetics/biotech/enzymes/nucleases.html
[20]  Rahman, N. (2011) Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection. The New England Journal of Medicine, 365, 518-526. https://doi.org/10.1056/NEJMoa1012740
[21]  Ninfa, A.J., Ballou, D.P. and Benore, M. (2010) Fundamental Laboratory Approaches for Biochemistry and Biotechnology. 2nd Edition, John Wiley & Sons, Hoboken, 234.

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal